Japan’s JCR Pharmaceuticals (TYO: 4552) closed 15% higher after Wednesday’s trading, as it signed a new licensing deal.

US pharma giant Merck & Co today revealed it has made a bid to acquire UK-based lung therapy company Verona Pharma, sending ...

Danish drugmaker Novo Nordisk (NOV: N) has filed for European approval of a higher-dose version of its obesity treatment ...

French biotech Ciloa is joining the race to treat type 2 diabetes and obesity, armed with 6.5 million euros ($7.6 million) in ...

New Jersey, USA-headquartered Champions Oncology, a translational oncology research organization, yesterday announced the ...

A new analysis from US data analytics firm Phesi has raised concerns about the viability of ongoing Phase III trials in ...

Radiopharmaceutical biotech Actithera today announced the close of an oversubscribed $75.5 million Series A financing round.

Donald Trump has escalated his warnings to the pharmaceutical industry with a pledge to introduce import tariffs as high as ...

The US Food and Drug Administration (FDA) and the National Institutes of Health (NIH) have hosted a hybrid workshop on reducing animal testing.

San Francisco, USA-based biotech Centivax, which is developing durable, universal vaccines, today announced the close of a ...

Prior to joining Crescent, Dr Pinkas was CSO at Pyxis Oncology (Nasdaq: PYXS), where he established the preclinical research ...

Debra Barker has been named chief medical officer (CMO) at Centauri Therapeutics, a UK immunotherapy company with a ...